Profiel
Scott Plevy served as Vice President at Janssen Pharmaceuticals, Inc. He then worked as Chief Scientific Officer at Synlogic, Inc. and Senda Biosciences, Inc. Currently, he is the Executive Vice President & Head-Gastroenterology at Protagonist Therapeutics, Inc. Dr. Plevy holds a doctorate degree from The Trustees of Columbia University in The City of New York.
Eerdere bekende functies van Scott Plevy
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 01-03-2024 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01-05-2019 |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Hoofd Techniek/Wetenschap/O&O | - |
| SYNLOGIC, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Scott Plevy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Synlogic, Inc.
Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
















